Skip to main content
Daily Report

Daily Cosmetic Research Analysis

04/28/2025
3 papers selected
3 analyzed

Three impactful studies in cosmetic science span safety, diagnosis, and regenerative aesthetics. A validated UHPLC-MS/MS workflow rapidly screens 64 prohibited drugs in cosmetics and detected violations in 6 of 20 market samples. Complementing polarized dermoscopy with ultraviolet-induced fluorescence dermoscopy improves characterization of basal cell carcinomas in the facial H-zone, while a hydroxyapatite-loaded hydrogel shows mechanistic potential to regenerate dermal ECM for facial rejuvenati

Summary

Three impactful studies in cosmetic science span safety, diagnosis, and regenerative aesthetics. A validated UHPLC-MS/MS workflow rapidly screens 64 prohibited drugs in cosmetics and detected violations in 6 of 20 market samples. Complementing polarized dermoscopy with ultraviolet-induced fluorescence dermoscopy improves characterization of basal cell carcinomas in the facial H-zone, while a hydroxyapatite-loaded hydrogel shows mechanistic potential to regenerate dermal ECM for facial rejuvenation.

Research Themes

  • Cosmetic product safety and analytical surveillance
  • Noninvasive skin cancer diagnostics in cosmetically sensitive regions
  • Regenerative biomaterials for aesthetic dermatology

Selected Articles

1. Rapid UHPLC-MS/MS Detection of Prohibited Drugs in Cosmetics Using Pass-Through SPE.

70Level IVCohort
ACS omega · 2025PMID: 40290927

The authors developed and validated a pass-through SPE UHPLC-MS/MS method that simultaneously quantifies 64 prohibited drugs across diverse cosmetic matrices with high recoveries and low LOQs. Applying the method to 20 marketed products identified banned substances in 6 samples, demonstrating real-world utility for regulatory surveillance.

Impact: Provides a comprehensive, rapid analytical workflow that can be adopted by regulators and industry to detect multiclass banned drugs in cosmetics, revealing noncompliance in real products.

Clinical Implications: Enhances consumer safety by enabling routine surveillance of cosmetic products for undeclared pharmacologically active substances; may inform recalls, risk assessments, and policy enforcement.

Key Findings

  • Validated simultaneous quantification of 64 prohibited drugs (11 categories) across toner, cream, and oil matrices.
  • Achieved recoveries of 70–120% with RSD <11% and LOQs of 0.1–1 μg/kg.
  • Detected prohibited substances in 6 of 20 market samples at concentrations spanning 7 orders of magnitude.
  • Pass-through SPE with PRiME HLB enabled rapid cleanup for diverse analyte polarities.

Methodological Strengths

  • Comprehensive multiclass panel with rigorous validation across multiple cosmetic matrices
  • Sensitive UHPLC-MS/MS quantitation with robust recoveries and precision

Limitations

  • Small market sample (n=20) limits prevalence estimates
  • Does not evaluate user exposure or toxicological risk from detected levels

Future Directions: Expand surveillance to larger, diverse product cohorts; integrate semi-quantitative risk thresholds; harmonize with regulatory labs for routine screening and international standards.

Prolonged exposure to drugs prohibited in cosmetics may cause irritation and allergic reactions in humans. In this study, a method using ultrahigh performance liquid chromatography-tandem mass spectrometry was established for the simultaneous determination of 64 prohibited drugs spanning 11 categories, including 39 antibiotics, 8 antiallergics, 7 anesthetics, and 10 hormones. Typical cosmetic samples containing toner, cream, and oil matrices were extracted using a 70% acetonitrile solvent system with 1% formic acid and purified using a pass-through cleanup solid-phase extraction approach with a PRiME hydrophobic-lipophilic balanced column. Analytes covering a wide range of polarities showed excellent recoveries between 70 and 120%, with relative standard deviations of <11%. Excellent sensitivities ranging from 0.1 to 1 μg/kg were achieved with the limits of quantification. This method provides a rapid and comprehensive targeted strategy for the analysis of multiclass prohibited drugs in various cosmetic matrices. Finally, analysis of 20 cosmetic products using the optimized method identified prohibited substances in 6 samples at concentrations spanning 7 orders of magnitude.

2. Hydroxyapatite microspheres encapsulated within hybrid hydrogel promote skin regeneration through the activation of Calcium Signaling and Motor Protein pathway.

69Level VCase series
Bioactive materials · 2025PMID: 40292340

Tailored hydroxyapatite microspheres within hyaluronate hydrogels promoted fibroblast function and physiologic collagen assembly by activating calcium and motor protein signaling with minimal adaptive immune activation. Benchmarking against PMMA and PLLA fillers indicates a regenerative, mechanism-driven alternative for facial rejuvenation.

Impact: Introduces a mechanistically informed, regenerative approach to soft-tissue augmentation that could shift aesthetic practice from passive fillers to active ECM remodeling.

Clinical Implications: If translated clinically, HAp-hydrogel systems may provide longer-lasting, more physiologic dermal regeneration with reduced inflammatory responses compared with traditional fillers.

Key Findings

  • HAp microspheres in hyaluronate hydrogels enhanced fibroblast function while eliciting minimal adaptive immune responses.
  • Activation of calcium signaling and motor protein pathways supported normal collagen fiber formation and ECM maturation.
  • Benchmarking versus PMMA and PLLA suggests HAp’s unique attributes are conducive to dermal regeneration and facial rejuvenation.

Methodological Strengths

  • Mechanistic pathway interrogation (calcium and motor protein signaling) linked to functional ECM outcomes
  • Head-to-head benchmarking against established dermal fillers (PMMA, PLLA)

Limitations

  • Preclinical study without human clinical data or long-term safety outcomes
  • Dose, particle characteristics, and degradation kinetics require optimization for clinical translation

Future Directions: Conduct in vivo large-animal studies and early-phase human trials to evaluate durability, safety, and aesthetic outcomes; refine particle size and surface chemistry for targeted dermal niches.

Hydroxyapatite (HAp), traditionally recognized for its efficacy in bone regeneration, has rarely been explored for skin regeneration applications. This investigation explored HAp microspheres with distinct physicochemical properties tailored away from conventional bone regeneration parameters, and the capacity promoting skin regeneration and mitigating the aging process were investigated when encapsulated in hyaluronate hydrogels. By benchmarking against well-established dermal fillers like PMMA and PLLA, it was revealed the specific attributes of HAp that were conducive to skin regeneration, providing initial insights into the underlying mechanism. HAp enhanced the fibroblast functionality by triggering minimal adaptive immune responses and enhancing the Calcium Signaling and Motor Protein Signaling pathways. This modulation supported the production of normal collagen fibers, essential for ECM maturation and skin structural integrity. The significant ECM regeneration and remodeling capabilities exhibited by the HAp-encapsulated hybrid hydrogels suggested promising application in facial rejuvenation procedures, potentially making a breakthrough in aesthetic and reconstructive surgery.

3. Polarized Dermoscopy and Ultraviolet-Induced Fluorescence Dermoscopy of Basal Cell Carcinomas in the H- and Non-H-Zones of the Head and Neck.

68.5Level IIICohort
Dermatology and therapy · 2025PMID: 40293692

In 151 head and neck BCCs, H-zone tumors showed distinct PD and UVFD profiles, including higher frequencies of ulceration and characteristic UVFD features (e.g., dark silhouettes, blue-fluorescent fibers, absent blue-green fluorescence). Adding UVFD to PD improves noninvasive characterization of BCCs in cosmetically critical facial areas.

Impact: Demonstrates incremental diagnostic value of UVFD alongside PD for BCC in high-risk facial subsites, informing earlier detection and potentially better cosmetic outcomes.

Clinical Implications: Incorporating UVFD into routine dermoscopic assessment may refine lesion characterization and guide biopsy or treatment planning, particularly in the facial H-zone.

Key Findings

  • Among 151 BCCs, 61.6% were in the facial H-zone, predominantly nodular (65.6%) and nonpigmented (86%).
  • UVFD features in H-zone BCCs frequently included dark silhouettes (77.4%), interrupted follicle patterns (51.6%), and absent blue-green fluorescence (51.6%).
  • Significant differences versus non-H-zone were observed for PD ulcerations (p=0.021) and multiple UVFD features (p=0.019, p=0.009, p=0.019).

Methodological Strengths

  • Standardized imaging with PD and UVFD using a single device and predefined criteria
  • Adequate sample size with stratification by anatomical risk zones and statistical comparisons

Limitations

  • Single-center design with potential selection bias
  • Cross-sectional imaging study without longitudinal outcomes or histopathologic correlation beyond BCC subtype

Future Directions: Prospective multicenter studies to validate UVFD diagnostic criteria, assess impact on management decisions, and develop automated fluorescence pattern analytics.

INTRODUCTION: Basal cell carcinoma (BCC) is the most common skin cancer, primarily affecting the head and neck region. This study aimed to evaluate the characteristics of BCCs in different facial areas using polarized dermoscopy (PD) and ultraviolet-induced fluorescence dermoscopy (UVFD). METHODS: BCCs were examined using a Dermlite DL5 dermatoscope in polarized and UVFD modes. The tumors were categorized based on their location within the high-risk H-zone (ear and periauricular region, temple, eyes and periorbital area, nose and paranasal region, oral region, chin) and non-H-zone (forehead, cheek, rest of the face, scalp, neck). PD features were characterized according to standard dermoscopic criteria for skin cancer assessment. UVFD characteristics included dark silhouettes, interrupted follicle patterns, ulcerations/erosions, white-blue scales, arborizing vessels, absence of pink-orange or blue-green fluorescence, blue-fluorescent fibers, pink-orange fluorescence, black globules, white depigmentation, white clods, and well-defined margins. RESULTS: A total of 151 BCCs were analyzed, with 61.6% located in the H-zone, where the nose and paranasal region were the most affected area (37.6%). Nodular (65.6%) and nonpigmented (86%) subtypes predominated in the H-zone. PD most commonly revealed arborizing vessels (52.7%), short fine telangiectasias (46.2%), red-white homogeneous areas (40.9%), and ulcerations/micro-ulcerations (40.9%). Under UVFD, BCCs in the H-zone frequently exhibited dark silhouettes (77.4%), interrupted follicle patterns (51.6%), absence of blue-green (51.6%) or pink-orange fluorescence (44%), and well-defined lesion borders (43%). Compared to non-H-zone tumors, BCCs in the H-zone were significantly more likely to display ulcerations/micro-ulcerations under PD (p = 0.021), and erosions/ulcerations (p = 0.019), blue-fluorescent fibers (p = 0.009), and absence of blue-green fluorescence (p = 0.019) under UVFD. CONCLUSION: BCCs in the head and neck exhibit distinct characteristics under UVFD, with certain findings more commonly observed in H-zone tumors. The addition of UVFD to PD serves as a valuable, noninvasive diagnostic tool that enhances early detection of BCCs in this anatomically and cosmetically significant region.